About Hamilton Thorne (CVE:HTL)
Hamilton Thorne Ltd., together with its subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets. The company offers clinical lasers, such as LYKOS and ZILOS-tk lasers, as well as clinical laser software and hardware for clinical assisted reproduction; and research lasers, including XYRCOS and XYClone lasers for stem cell research, gene targeting, knock out mouse production, SCNT, ICSI, IVF, and assisted hatching applications, as well as Stiletto lasers for isolation of cells of interest, ablation of unwanted cells, and precision scoring of cell colonies. It also provides clinical sperm analysis (CASA) products comprising IVOS II Clinical and CEROS II Clinical, as well as Human Motility II and Dimensions II Strict Morphology software to clinics, hospitals, and laboratories; animal and research CASA systems, and motility software packages; and various sperm analyzer options. In addition, the company offers sperm analysis accessories, such as Accu-beads+ for use in counting procedures in semen analysis; 2X-CEL disposable semen analysis slides; IDENT Stains for determining sperm motility and concentration; VIADENT stain to determine viable sperm count, concentration, and percentage from a motile sample; and MiniTherm Stage Warmer for CASA and manual sperm motility analysis. Further, it offers IMSI-Strict, an automated software solution for live sperm morphology under high magnification; Oosight imaging system for research purposes; and CIVA, a custom software to capture images/video and annotate. The company sells its products to pharmaceutical and biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Hamilton Thorne Ltd. is based in Beverly, Massachusetts.
Industry, Sector and Symbol:
- Industry: Medical Appliances & Equipment
- Sub-Industry: N/A
- Sector: Healthcare
- Symbol: CVE:HTL
- CUSIP: N/A
- Web: www.hamiltonthorne.com
- Trailing EPS: C$0.01
- Net Margins: 0.55%
- Return on Equity: 1.32%
- Return on Assets: 0.56%
- Outstanding Shares: 107,259,000
Frequently Asked Questions for Hamilton Thorne (CVE:HTL)
What is Hamilton Thorne's stock symbol?
Hamilton Thorne trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HTL."
When will Hamilton Thorne make its next earnings announcement?
Who are some of Hamilton Thorne's key competitors?
Some companies that are related to Hamilton Thorne include Knight Therapeutics (GUD), Nobilis Health Corp. (HLTH), Cannabis Science (CBIS), Vernalis plc (VER), Electromed (ELMD), Concordia International Corp (CXR), Venture Life Group Plc (VLG), Cytori Therapeutics (CYTX), Baxano Surgical (BAXSQ), Savient Pharmaceuticals (SVNTQ), NephroGenex (NRXGQ), Alexza Pharmaceuticals (ALXA), Allos Therapeutics (ALTH), Amgen Rockville (MITI), Amylin Pharmaceuticals LLC (AMLN), Ardea Biosciences (RDEA), ArthroCare Corporation (ARTC) and Avanir Pharmaceuticals (AVNR).
Who are Hamilton Thorne's key executives?
Hamilton Thorne's management team includes the folowing people:
- Meg D. Spencer, Chairman of the Board
- David Wolf, President, Chief Executive Officer, Director, IR Contact Officer
- Michael W. Bruns CPA, Chief Financial Officer, Vice President - Finance
- Diarmaid H. Douglas-Hamilton, Corporate Secretary, Chief Technology Officer and Senior Vice-President - Research & Development of the Corporation, Director
- Thomas Kenny, Vice President - Engineering
- David B. Sable M.D., Director
- Dean Gendron, Independent Director
- Bruno C. Maruzzo, Independent Director
- Robert J. Potter, Independent Director
- Daniel K. Thorne, Independent Director
How do I buy Hamilton Thorne stock?
Shares of Hamilton Thorne and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Hamilton Thorne's stock price today?
One share of Hamilton Thorne stock can currently be purchased for approximately C$0.71.
How big of a company is Hamilton Thorne?
Hamilton Thorne has a market capitalization of C$85.17 million.
How can I contact Hamilton Thorne?
MarketBeat Community Rating for Hamilton Thorne (CVE HTL)MarketBeat's community ratings are surveys of what our community members think about Hamilton Thorne and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Hamilton Thorne's mailing address is 100 Cummings Ctr Ste 465e, BEVERLY, MA 01915-6143, United States. The company can be reached via phone at +1-978-9212050.
Analysts' Consensus Ratings for Hamilton Thorne (CVE:HTL) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 3.00)|
|Analysts' Consensus Price Target: ||N/A|Consensus Price Target History for Hamilton Thorne (CVE:HTL)
Analysts' Ratings History for Hamilton Thorne (CVE:HTL)
(Data available from 11/17/2015 forward)
|10/25/2017||Bloom Burton||Reiterated Rating||Buy|
Earnings History for Hamilton Thorne (CVE:HTL)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Hamilton Thorne (CVE:HTL)
2017 EPS Consensus Estimate: $0.03
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Hamilton Thorne (CVE:HTL)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Hamilton Thorne (CVE HTL)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Hamilton Thorne (CVE:HTL)
Latest Headlines for Hamilton Thorne (CVE HTL)
Financials are not available for this stock.
Hamilton Thorne (CVE HTL) Chart for Friday, November, 17, 2017